<DOC>
	<DOC>NCT00996879</DOC>
	<brief_summary>The purpose of this study is to assess the effect of BMS-791325 on the pharmacokinetics of the CYP3A4 Probe Midazolam.</brief_summary>
	<brief_title>Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Healthy male and female subjects aged 18 to 49 years, with BMI of 1832 kg/mÂ² Women who are not of childbearing potential Women of childbearing potential Women who are pregnant, breastfeeding, or unwilling or unable to use an acceptable method of birth control. Gastrointestinal disease that may impact the absorption of study drug History of any chronic respiratory disease (asthma, COPD)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Human Volunteers</keyword>
</DOC>